India-Afghanistan Sign $100 Million Pharmaceutical Deal in Major Trade Shift Away From Pakistan

Nov 28, 2025 10:32 am CST

A landmark $100 million pharmaceutical agreement between India's Zydus Lifesciences and Afghanistan's Rofi's International Group signals a significant transformation in regional trade dynamics. Following the Taliban's recent ban on Pakistan trade, this deal represents Afghanistan's strategic pivot toward India for healthcare development and commercial partnerships, with plans for medicine exports and eventual domestic manufacturing in Afghanistan.